Cambridge Investment Research Advisors’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,618
| Closed | -$37K | – | 2507 |
|
|
2019
Q3 | $37K | Buy |
12,618
+2,602
| +26% | +$5.34K | ﹤0.01% | 2300 |
|
|
2019
Q2 | $19K | Hold |
10,016
| – | – | ﹤0.01% | 2181 |
|
|
2019
Q1 | $19K | Hold |
10,016
| – | – | ﹤0.01% | 2257 |
|
|
2018
Q4 | $15K | Sell |
10,016
-69
| -0.7% | -$138 | ﹤0.01% | 2133 |
|
|
2018
Q3 | $24K | Sell |
10,085
-9,481
| -48% | -$20.5K | ﹤0.01% | 2221 |
|
|
2018
Q2 | $53K | Buy |
19,566
+3
| +0% | +$9 | ﹤0.01% | 2154 |
|
|
2018
Q1 | $58K | Buy |
19,563
+945
| +5% | +$3.1K | ﹤0.01% | 2092 |
|
|
2017
Q4 | $60K | Buy |
18,618
+5,058
| +37% | +$44.2K | ﹤0.01% | 2057 |
|
|
2017
Q3 | $207K | Hold |
13,560
| – | – | ﹤0.01% | 1809 |
|
|
2017
Q2 | $272K | Hold |
13,560
| – | – | ﹤0.01% | 1563 |
|
|
2017
Q1 | $136K | Buy |
13,560
+152
| +1% | +$1.69K | ﹤0.01% | 1674 |
|
|
2016
Q4 | $127K | Sell |
13,408
-3,312
| -20% | -$35.5K | ﹤0.01% | 1572 |
|
|
2016
Q3 | $181K | Hold |
16,720
| – | – | ﹤0.01% | 1581 |
|
|
2016
Q2 | $288K | Buy |
16,720
+3,995
| +31% | +$124K | 0.01% | 1195 |
|
|
2016
Q1 | $477K | Sell |
12,725
-327
| -3% | -$13.1K | 0.01% | 925 |
|
|
2015
Q4 | $891K | Sell |
13,052
-5
| -0% | -$359 | 0.02% | 593 |
|
|
2015
Q3 | $754K | Buy |
+13,057
| New | +$1.16M | 0.02% | 582 |
|
|
2014
Q4 | – | Sell |
-13,821
| Closed | -$601K | – | 1521 |
|
|
2014
Q3 | $601K | Buy |
+13,821
| New | +$647K | 0.02% | 719 |
|
|
2013
Q4 | – | Sell |
-12,890
| Closed | -$847K | – | 1295 |
|
|
2013
Q3 | $847K | Buy |
+12,890
| New | +$1.04M | 0.04% | 420 |
|
Cambridge Investment Research Advisors's FCSC Position: Q4 2019 in Review
Cambridge Investment Research Advisors sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 12,618 shares — an estimated $37K sold.
Cambridge Investment Research Advisors first reported a position in FCSC in Q3 2013 and held it in 19 quarters. The position peaked at $891K in Q4 2015. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Cambridge Investment Research Advisors reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 12,618 Fibrocell Science Inc. shares in Q4 2019, an estimated $37K.
- Cambridge Investment Research Advisors first reported a position in Fibrocell Science Inc. in Q3 2013 and held it in 19 quarters.
- Cambridge Investment Research Advisors's Fibrocell Science Inc. position peaked at $891K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.